PharVision Advisers LLC bought a new stake in Ingredion Incorporated (NYSE:INGR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,871 shares of the company's stock, valued at approximately $257,000.
A number of other large investors also recently modified their holdings of the company. Barclays PLC boosted its holdings in Ingredion by 31.9% in the 3rd quarter. Barclays PLC now owns 47,291 shares of the company's stock valued at $6,499,000 after purchasing an additional 11,432 shares during the period. Park Avenue Securities LLC raised its stake in Ingredion by 12.8% in the fourth quarter. Park Avenue Securities LLC now owns 3,865 shares of the company's stock valued at $532,000 after purchasing an additional 440 shares in the last quarter. Merit Financial Group LLC purchased a new position in Ingredion in the 4th quarter worth approximately $314,000. Ballentine Partners LLC bought a new position in shares of Ingredion in the 4th quarter worth $206,000. Finally, Crossmark Global Holdings Inc. raised its position in shares of Ingredion by 143.1% during the 4th quarter. Crossmark Global Holdings Inc. now owns 13,536 shares of the company's stock valued at $1,862,000 after buying an additional 7,969 shares in the last quarter. 85.27% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
INGR has been the topic of a number of research analyst reports. Wall Street Zen raised shares of Ingredion from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 19th. UBS Group set a $155.00 target price on shares of Ingredion in a research note on Tuesday, April 22nd. Stephens decreased their target price on Ingredion from $155.00 to $150.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 5th. BMO Capital Markets cut their price objective on Ingredion from $147.00 to $133.00 and set a "market perform" rating for the company in a report on Wednesday, February 5th. Finally, Oppenheimer decreased their price target on shares of Ingredion from $167.00 to $155.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 22nd. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Ingredion has an average rating of "Moderate Buy" and a consensus target price of $152.20.
Get Our Latest Report on Ingredion
Insider Buying and Selling
In related news, SVP Larry Fernandes sold 2,400 shares of the company's stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $135.82, for a total value of $325,968.00. Following the completion of the sale, the senior vice president now directly owns 31,996 shares of the company's stock, valued at $4,345,696.72. This represents a 6.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.80% of the stock is owned by insiders.
Ingredion Stock Down 1.0%
INGR stock traded down $1.39 on Wednesday, hitting $138.03. 98,677 shares of the company's stock were exchanged, compared to its average volume of 469,958. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.69 and a current ratio of 2.62. Ingredion Incorporated has a 12-month low of $111.54 and a 12-month high of $155.44. The stock has a market cap of $8.88 billion, a P/E ratio of 14.21, a price-to-earnings-growth ratio of 1.03 and a beta of 0.73. The firm has a 50 day moving average price of $133.18 and a two-hundred day moving average price of $135.45.
Ingredion (NYSE:INGR - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $2.97 EPS for the quarter, topping the consensus estimate of $2.44 by $0.53. Ingredion had a net margin of 8.71% and a return on equity of 18.62%. The company had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same quarter in the previous year, the firm earned $2.08 EPS. The firm's revenue was down 3.7% compared to the same quarter last year. As a group, equities research analysts expect that Ingredion Incorporated will post 11.14 EPS for the current fiscal year.
Ingredion Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 22nd. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date is Tuesday, July 1st. Ingredion's dividend payout ratio is currently 33.76%.
Ingredion Profile
(
Free Report)
Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.
Featured Stories

Before you consider Ingredion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.
While Ingredion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.